242PImpact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). (23rd October 2018) - Olympios, N; Lambertini, M; Calbrix, C; Saint-Ghislain, M; Fontanilles, M; Loeb, A; Leheurteur, M; Demeestere, I; Di Fiore, F; Perdrix, A; Clatot, F